Events
Start of main content

Metabolism, Model Systems and Therapies for ALS
Life and Matter Sciences Session Tuesday, July 2, 2019 9:45 hours Madrid
General information:
Venue: Fundación Ramón Areces. Calle Vitruvio, 5. 28006. Madrid.
Free admission. Necessary previous online registration. Limited capacity. Simultaneous interpretation.
Organized by:
Fundación Ramón Areces
In cooperation with:
Fundación Francisco Luzón
Coordinator/s:
Mónica Povedano. Hospital Universitario de Bellvitge.
Isidro Ferrer. Hospital Universitario de Bellvitge.
Multimedia
Kevin Talbot's full lecture
Multimedia
Hèléne Blasco's full lecture
Multimedia
Abraham Acevedo Arozena's full lecture
Multimedia
María Demestre's full lecture
Multimedia
Ana Martínez Gil's full lecture
- Description
- Programme
The search for efficient therapies for the treatment of the Amyotrophic Lateral Sclerosis (ALS) requires a translational scientific approach, a research using model systems of the disease with a fast and bidirectional communication with the clinic research.
Fundación Ramón Areces and Francisco Luzón Foundation collaborate organizing this workshop with the aim of creating an environment where the researchers working on ALS, could have the opportunity of share information of the new advances in the field among them and with the public interested in attendance to this workshop.
Along the workshop there will be three main topics to be focused on among the multiple ones composing the research on ALS environment. In first place, we will talk about metabolic alterations in ALS patients, the second topic will be the use of model systems as an approach for the research on ALS. Finally, we will talk about the therapeutic approach to this pathology.
In the workshop there will be the participation of prestigious international and national researchers, preceded by the plenary talk by Dr. Talbot from Oxford University.
Tuesday, July 2
9:15 h.
Attendee check-in
9:45 h.
Welcome
Raimundo Pérez-Hernández y Torra
Director Fundación Ramón Areces.
Federico Mayor Zaragoza
Consejo Científico Fundación Ramón Areces.
María José Arregui
Vicepresidenta Ejecutiva de la Fundación Francisco Luzón.
Teresa Chavarría
Directora General de Planificación, Investigación y Formación de la Consejería de Sanidad de la Comunidad de Madrid.
10:15 h.
Principal conference: Modelling amyotrophic lateral sclerosis in the era of precision medicine
Kevin Talbot
Head of the Division of Clinical Neurology. Nuffield Department of Clinical Neurosciences. University of Oxford. United Kingdom.
11:00 h.
Metabolic alteration in ALS
Moderator:
Francisco Gil Bea
Instituto de Investigación Sanitaria Biodonostia. CIBERNED (ISCIII).
Speaker:
Hélène Blasco
Université de Tours, France.
11:35 h.
Break
12:00 h.
ALs Models
Moderator:
Josep Esquerda
Universitat de Lleida.
Speakers:
Murine models of ALS
Abraham Acevedo Arozena
Unidad de Investigación del Hospital Universitario de Canarias, Fundación Canaria de Investigación Sanitaria (FUNCANIS). CIBERNED (ISCIII).
Human in vitro models to reconstruct pathogenic mechanisms in ALS
María Demestre
Stem Cell Group. University of Ulm. Germany.
13:10 h.
Targeting TDP-43 with protein kinase inhibitors as a new therapeutic strategy for ALS
Moderator:
Ana Cristina Calvo
Universidad de Zaragoza.
Speakers:
Ana Martínez Gil
Centro de Investigaciones Biológicas (CIB-CSIC - CIBERNED (ISCIII) ). Consorcio ELA-Madrid.
13:45 h.
Closing remarks
Alejandro Arranz
Director General de Investigación e Innovación de la Consejería de Educación e Investigación de la Comunidad de Madrid.
-
Activities related
-
Projects related
-
News related
-
Publications related
-
26
Oct
2021
Jornada online Ensayos clínicos y búsqueda de nuevas dianas terapéuticas contra la ELA ONLINE desde: www.fundacionareces.tv/directo, Tuesday, 26 October 2021, 19:00 hours
-
22
Jun
2022
International Symposium Cuidados paliativos globales: retos y expectativas futuras Madrid, Wednesday, 22 June 2022, 16:00 hours
-
27
Oct
2022
Scientific Symposium Mecanismos de muerte celular en la ELA: posibilidades para el manejo clínico de la enfermedad. VI Encuentro internacional de la ELA en España Madrid, Thursday, 27 October 2022, 16:00 hours
- Significance of brain glucose hypometabolism and of altered insulin signal transduction in an experimental model of amiotrophic lateral esclerosis (ALE) 2018 Senior Researcher : Enrique Blázquez Fernández Research Centre or Institution : Universidad Complutense de Madrid
- Investigation on hybrid molecules as powerful novel therapeutic approaches for Multiple Sclerosis and myelin- related rare diseases 2018 Senior Researcher : Fernando de Castro Soubriet Research Centre or Institution : Instituto Cajal. CSIC. Madrid.
- Progression of different forms of multiple sclerosis related to the stem/progenitor cells potential 2018 Senior Researcher : Laura López Mascaraque Research Centre or Institution : Instituto Cajal. CSIC. Madrid.

End of main content